wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35051306-3FF06D58-6D45-43FB-83D8-1F4154DE1F94
Q35051306-3FF06D58-6D45-43FB-83D8-1F4154DE1F94
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35051306-3FF06D58-6D45-43FB-83D8-1F4154DE1F94
Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing state.
P2860
Q35051306-3FF06D58-6D45-43FB-83D8-1F4154DE1F94
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35051306-3FF06D58-6D45-43FB-83D8-1F4154DE1F94
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f11af205cd7525420fdc1080229e6ddbcd7f452
P2860
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.